✦ LIBER ✦

Cyclophosphamide or ifosfamide in patients with advanced and/or recurrent endometrial carcinoma: a randomized phase II study of the EORTC Gynecological Cancer Cooperative Group

✍ Scribed by A. Pawinski; S. Tumolo; G. Hoesel; A. Cervantes; A.T. van Oosterom; G. Hoctin Boes; S. Pecorelli

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of carboplatin in patient

✍ F.H van Wijk; C Lhommé; G Bolis; V Scotto di Palumbo; S Tumolo; M Nooij; C.F de 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Phase II trial of vinorelbine in patient

✍ C. Lhommé; J.B. Vermorken; E. Mickiewicz; B. Chevalier; A. Alvarez; C. Mendiola; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 97 KB

A Phase II Trial of Topotecan in Patient

✍ David Scott Miller; John A. Blessing; Samuel S. Lentz; Steven E. Waggoner 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Phase II trial of danazol in advanced, r

✍ Allan Covens; Virginia L Brunetto; Maurie Markman; James W Orr Jr.; Samuel S Len 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 72 KB

A Phase II Trial of Anastrozole in Advan

✍ Peter G. Rose; Virginia L. Brunetto; Linda VanLe; Jeffrey Bell; Joan L. Walker; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Phase II Trial of Pyrazoloacridine in Pa

✍ Steven C. Plaxe; John A. Blessing; Nader Husseinzadeh; Kenneth D. Webster; Janet 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 39 KB